THE success of nano-derived compounds in treating triple negative breast cancer (TNBC) was the subject of a study at the Arabian Gulf University (AGU) and Princess Al Jawhara Centre for Molecular Medicine, Genetics and Inherited Disorders, Manama.
TNBC is an intractable tumour that does not respond to conventional chemotherapy and has very little recovery rates among patients .